Medical Marijuana, Inc. (OTC:MJNA) confirmed Tuesday that its subsidiary Kannaway achieved its largest income month within the firm’s historical past in its Japan and South Africa divisions in January 2022.
“With the ability to obtain 4 finest income months in a row within the Japan market has been each an effective way to finish 2021 and an inspiring technique to begin 2022,” Medical Marijuana, Inc. CEO Blake Schroeder said. “Now that we’ve reached this milestone in South Africa as nicely, we anticipate that each areas will probably be main market areas for us this yr and past.”
In line with Enterprise Insider Africa, Africa’s hashish business is projected to develop past a $7 billion valuation by 2023. Attain and Markets highlights that the Asia-Pacific market can also be anticipated to develop exponentially with a CAGR of 28.6% from 2020 to 2027.
Medical Marijuana shares traded 0.60% greater at $0.0167 per share on the time of writing Tuesday morning.